Aptus Pharma Ltd - 544529 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Aptus Pharma Ltd announced strong FY26 standalone results. Revenue grew 89.59% to Rs.46.71 crores, and net profit increased 49.05% to Rs.4.62 crores. EBIDTA was up 57.73% at Rs.7.50 crores, reflecting robust operational performance and product expansion.
Apr 28 2026 20:04:00
Aptus Pharma Ltd - 544529 - Intimation Of Record Date For Issue Of Bonus Shares
Aptus Pharma set May 12, 2026, as Record Date for its bonus share issue. Eligible shareholders will receive 3 equity shares for every 2 existing shares held, reflecting a 3:2 ratio.
Apr 27 2026 21:04:00
Aptus Pharma Ltd - 544529 - Board Meeting Outcome for Outcome Of Board Meeting Held On 27Th April, 2026.
Aptus Pharma board approved audited financial results for FY26, reporting ₹461.99 lacs net profit and ₹4,657.46 lacs revenue. The board also approved a 3:2 bonus share issue with the record date set as May 12, 2026.
Apr 27 2026 19:04:00
Aptus Pharma Ltd - 544529 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Aptus Pharma shareholders approved resolutions to increase authorized share capital and issue bonus shares in a 3:2 ratio. This move enhances the capital structure and directly rewards existing shareholders.
Apr 25 2026 19:04:00
Read More